Table 3 Clinicopathological associations of both DNER and β-catenin expression in breast cancer.
Variables | Low N = 70 | High N = 36 | P value* |
|---|---|---|---|
Age at diagnosis, years | 0.945 | ||
≤50 | 19 (27.1) | 10 (27.8) | |
>50 | 51 (72.9) | 26 (72.2) | |
Grade | 0.038 | ||
Well | 15 (21.4) | 2 (5.6) | |
Moderately | 19 (27.2) | 7 (19.4) | |
Poorly | 36 (51.4) | 27 (75.0) | |
Tumour size (cm) | 0.004 | ||
≤2 | 38 (54.3) | 9 (25.0) | |
>2 | 32 (45.7) | 27 (75.0) | |
Lymph node metastasis | 0.415 | ||
Negative | 27 (38.6) | 11 (30.6) | |
Positive | 43 (61.4) | 25 (69.4) | |
Vascular invasion | 0.113 | ||
Negative | 58 (82.9) | 25 (69.4) | |
Positive | 12 (27.1) | 11 (30.6) | |
ER | 0.665 | ||
Negative | 58 (82.9) | 31 (86.1) | |
Positive | 12 (27.1) | 5 (13.9) | |
PR | 0.003 | ||
Negative | 40 (57.1) | 31 (86.1) | |
Positive | 30 (42.9) | 5 (13.9) | |
HER2 | 0.057 | ||
Negative | 46 (65.7) | 30 (83.3) | |
Positive | 24 (34.3) | 6 (16.7) | |
Ki67 | 0.183 | ||
<14 % | 55 (78.6) | 24 (66.7) | |
≥14 % | 15 (21.4) | 12 (33.3) | |
Recurrence | < 0.01 | ||
No | 62 (88.6) | 20 (55.6) | |
Yes | 8 (11.4) | 16 (44.4) |
